期刊文献+

慢性阻塞性肺疾病急性加重患者血清降钙素原水平变化的临床意义 被引量:4

Clinical Significance of PCT Level Change in AECOPD
下载PDF
导出
摘要 目的动态监测降钙素原(PCT)水平,指导抗生素在AECOPD患者中的使用,减少不必要的抗生素暴露时间。方法入选当日血清PCT≥0.5μg/L的27例AECOPD患者为PCT组,同期随机选择30例AECOPD患者为常规治疗组。PCT组根据血清PCT水平决定抗生素的使用,如PCT<0.25μg/L停用抗生素;常规治疗组根据患者临床症状、体温、WBC计数、CRP水平决定抗生素的使用。主要观察指标为抗生素的使用天数、抗生素费用等。结果 PCT组的抗生素使用天数(10.30±2.76)d,常规治疗组(13.47±1.38)d,PCT组的抗生素费用(3525.76±1162.96)元,常规治疗组(4706.72±803.04)元,两组患者差异有显著性(P<0.01)。结论 PCT水平能指导抗生素在AECOPD患者中的使用,减少不必要的抗生素暴露时间。 Objective To monitor PCT level dynamically and guide the use of antibiotics in AECOPD in an attempt to reduce the unnecessary antibiotic exposure time. Methods We chose on the same day 27 cases of AECOPD whose blood serum PCT≥0.5 μg/L as PCT group, and then chose 30 cases of AECOPD as routine therapy group. In the PCT group, the serum PCT level was taken as standard of using the quantity of antibiotic, and when the PCT〈0.25 μ g/L, we stopped using antibiotic. In the routine therapy group, the antibiotic treatment was carried out according to clinical symptoms, body temperature, WBC account, and CRP level. The main observation indexes were the days and cost of using antibiotic and so on. Results There were (10.30 ± 2.76)d in the days of using antibiotic in the PCT group, and (13.47 ±1.38) d in the routine therapy group, and in the cost of using antibiotic, the PCT group showed (3525.76 ±1162.96) yuan, and the routine group, (4706.72 ± 803.04) yuan, with a significant difference between the two groups (P〈0.01). Conelusion PCT level can guide the use of an- tibiotics in AECOPD, which is meaningful to reduce the unnecessary antibiotic exposure time.
出处 《中国现代医生》 2010年第28期21-23,共3页 China Modern Doctor
关键词 慢性阻塞性肺病 抗生素治疗 降钙素原 COPD Antibiotic therapy PCT
  • 相关文献

参考文献9

  • 1Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects[J]. Clin Endocrinol, 1994,79:1605-1608.
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 3Anthonisen NR,Manfreda J,Warren CP,et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease[J]. Annlntern Med, 1987,106(2): 196-204.
  • 4Rutshmann OT, Comur J, Poletti PA,et al. Should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease[J]. Thorax, 2007, 62(2): 121-125.
  • 5Lindenauer PK, Pekow P,Gao S,et al. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease[J]. Ann Intern Med, 2006, 144(12): 894-903.
  • 6杨滨,康梅.降钙素原在细菌感染性疾病诊断及治疗中的应用[J].现代预防医学,2009,36(3):596-597. 被引量:111
  • 7Claeys R,Vinken S, Spapen H,et al. Plasma procalcitonin and C reactive protein in acute septic shock: clinical and biological correlates[J]. Crit Care Med, 2002,30: 757-762.
  • 8Stolz D,Christ-Criain M, Bingisser R,et al. Antibiotic treatment of exacerbation of COPD: a randomized, controlled trial comparing procalcitonin guidance with standard therapy[J]. Chest, 2007, 131 (1) : 9-19.
  • 9Schuetz P, Christ-Crain M,Wolbers M,et al. Procalcitonin guide antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial[J]. BMC Health Serv Res,2007,7:102.

二级参考文献19

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2俞娅芬,陈德昌,宋秀琴.早期诊断严重脓毒症 脓毒性休克研究进展[J].中国急救医学,2007,27(2):154-156. 被引量:56
  • 3Mirjam Christ-Crain, Beat Miiller. Procalcitonin in bacterial infections-hype, hope, more or less [J]? Swiss Med Wkly, 2005, 135: 451--460.
  • 4Muller B, White JC, Nylen E, et al. Ubiquitous expression of the ealcitortin-1 gene in multiple tissues in response to sepsis [J]. J Clin Endocrinol Metab, 2001, 86: 396-404.
  • 5Philippe Linseheid, Dalma Seboek, Eric S. Nylen, et al. In Vitro and in Vivo Caleitonin I Gene Expression in Parenchymal Cells: A Novel Product of Human Adipose Tissue [J]. Endocrinology, 2003, 144: 5578-5584.
  • 6Meisner M., Procalcitonin (PCT) A new, innovative infection parameter.; Biochemical and clinical aspects; ISBN: 3-13- 105503-0 [S]. Thieme Stuttgart, New York, 2000.
  • 7Mirjam Christ-Crain, Dalana Stolz, Roland Bingisser, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia [J]. American journal of respiratory and critical care medicine, 2006, 174: 84-93.
  • 8Daiana Stolz, Miriam Christ-Crain, Roland Bingisser, et al. Antibiotic Treatment of Exacerbations of COPD [J]. Chest, 2007, 1 : 9-19.
  • 9Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitanin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial [J]. Lancet, 2004, 363: 600-607.
  • 10Jens Ulrik Jensen, Lars Heslet, Tom Hartvig Jensen et al. Procalcitonin increase in early identifucation of critically ill patients at high risk of mortality [J]. Crit care med, 2006, 34: 2596-2602.

共引文献8342

同被引文献30

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部